Back to Search
Start Over
level <= 4.0 ng per milliliter
- Source :
- The New England Journal of Medicine. May 27, 2004, Vol. 350 Issue 22, p2239, 2246 p.
- Publication Year :
- 2004
-
Abstract
- A study was conducted, in the prostate cancer prevention trial, to investigate the prevalence of prostate cancer among men who had a prostate-specific antigen (PSA) level of 4.0 ng per milliliter or less. The result shows the percentage of prevalence of prostate cancer among men, and reveals that the biopsy-detected prostate cancer is not rare among men with PSA levels of 4.0 ng per milliliter or less.
Details
- Language :
- English
- ISSN :
- 00284793
- Volume :
- 350
- Issue :
- 22
- Database :
- Gale General OneFile
- Journal :
- The New England Journal of Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.120300840